Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
ACAD [NASD]
ACADIA Pharmaceuticals Inc.
Index- P/E- EPS (ttm)-0.67 Insider Own0.10% Shs Outstand99.44M Perf Week3.80%
Market Cap2.61B Forward P/E- EPS next Y-0.59 Insider Trans21.03% Shs Float99.18M Perf Month-2.16%
Income-62.10M PEG- EPS next Q-0.22 Inst Own96.00% Short Float16.68% Perf Quarter27.30%
Sales0.30M P/S8701.00 EPS this Y-15.80% Inst Trans0.26% Short Ratio13.89 Perf Half Y35.87%
Book/sh3.65 P/B7.19 EPS next Y29.40% ROA-22.10% Target Price34.92 Perf Year19.21%
Cash/sh3.56 P/C7.36 EPS next 5Y20.00% ROE-23.00% 52W Range15.64 - 32.00 Perf YTD5.04%
Dividend- P/FCF- EPS past 5Y24.00% ROI-21.00% 52W High-17.97% Beta2.72
Dividend %- Quick Ratio38.60 Sales past 5Y-7.20% Gross Margin- 52W Low67.84% ATR1.27
Employees48 Current Ratio38.60 Sales Q/Q-93.80% Oper. Margin- RSI (14)56.41 Volatility3.80% 5.42%
OptionableYes Debt/Eq0.00 EPS Q/Q-100.00% Profit Margin- Rel Volume0.65 Prev Close25.92
ShortableYes LT Debt/Eq0.00 EarningsNov 04 AMC Payout- Avg Volume1.19M Price26.25
Recom1.90 SMA204.92% SMA504.35% SMA20012.79% Volume782,700 Change1.27%
07-Aug-13Reiterated Needham Buy $16 → $26
07-Aug-13Reiterated Ladenburg Thalmann Buy $15 → $24
07-Aug-13Downgrade MLV & Co Buy → Hold $18 → $20
11-Apr-13Reiterated Needham Buy $9 → $16
11-Apr-13Reiterated MLV & Co Buy $12.50 → $18
11-Apr-13Reiterated Ladenburg Thalmann Buy $9 → $15
13-Mar-13Reiterated Ladenburg Thalmann Buy $8 → $9
28-Nov-12Reiterated MLV & Co Buy $4.50 → $8.50
27-Nov-12Upgrade Needham Hold → Buy $9
27-Nov-12Reiterated Ladenburg Thalmann Buy $8
30-Apr-12Initiated Ladenburg Thalmann Buy
01-Sep-09Downgrade Citigroup Hold → Sell
05-May-09Upgrade JMP Securities Mkt Perform → Mkt Outperform $7
06-Aug-08Downgrade JMP Securities Mkt Outperform → Mkt Perform
08-Jul-08Upgrade Banc of America Sec Sell → Neutral
17-Jun-08Downgrade Jefferies & Co Buy → Hold $14 → $4
17-Jun-08Downgrade Friedman Billings Outperform → Mkt Perform $21 → $8
17-Jun-08Downgrade Banc of America Sec Buy → Sell
06-May-08Reiterated Brean Murray Sell $7 → $6
07-Mar-08Reiterated Fortis Bank Buy $22 → $23
12-Sep-14 06:00AM  Jim Cramer's Top Stock Picks: TWTR TASR ACAD ISIS RH at TheStreet
11-Sep-14 06:43PM  Biotech targets: Cramer's quality candidates at CNBC
06:40PM  [video] Cramer: ACAD and ISIS have room to run at CNBC
06-Sep-14 03:33AM  [$$] Charting the Market at Barrons.com
02-Sep-14 02:38PM  Why ACADIA Pharmaceuticals (ACAD) Stock Is Spiking Today at TheStreet +10.97%
01:34PM  Compuware Climbs On Buyout Announcement at TheStreet
09:02AM  ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Other Events EDGAR Online
09:00AM  ACADIA Pharmaceuticals Receives FDA Breakthrough Therapy Designation for NUPLAZID (Pimavanserin) for Parkinsons Disease Psychosis Business Wire
28-Aug-14 09:00AM  ACADIA Pharmaceuticals Announces Trade Name NUPLAZID for Pimavanserin Business Wire
12-Aug-14 01:04PM  ACADIA PHARMACEUTICALS INC Financials EDGAR Online Financials
06-Aug-14 08:30AM  ACAD: Acadia On Track With Pimavanserin Development Program Zacks Small Cap Research
05-Aug-14 05:00PM  ACADIA Pharmaceuticals Inc Earnings Call scheduled for 5:00 pm ET today CCBN
04:03PM  ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online
04:01PM  ACADIA Pharmaceuticals Reports Second Quarter 2014 Financial Results Business Wire
07:07AM  Q2 2014 ACADIA Pharmaceuticals Earnings Release - After Market Close CCBN
29-Jul-14 09:00AM  ACADIA Pharmaceuticals to Announce Second Quarter 2014 Financial Results on August 5, 2014 Business Wire
24-Jul-14 12:34PM  [video] Who's afraid of Janet Yellen? at CNBC
15-Jul-14 09:04AM  ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online -5.98%
09:00AM  ACADIA Pharmaceuticals Announces Appointment of Stephen Davis as Executive Vice President, Chief Financial Officer and Chief Business Officer Business Wire
26-Jun-14 04:50PM  Are Investors Wrong About Acadia Pharmaceuticals? at Motley Fool
17-Jun-14 09:00AM  ACADIA Pharmaceuticals to Present at the 9th Annual JMP Securities Healthcare Conference on June 24, 2014 Business Wire
09-Jun-14 04:37PM  ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
04-Jun-14 01:26PM  Investors Grab Acadia Pharmaceuticals 30% Cheaper Than Its Secondary Stock Offering at Forbes +5.16%
27-May-14 09:00AM  ACADIA Pharmaceuticals to Present at the Jefferies 2014 Global Healthcare Conference on June 2, 2014 Business Wire
15-May-14 12:23PM  Midday movers: NFLX, PCLN, BIIB & more at CNBC
06:39AM  ACADIA initiated with an Overweight at JPMorgan at theflyonthewall.com
07-May-14 10:41AM  Acadia Remains On Track With Pimavanserin Program at Seeking Alpha
06-May-14 10:42PM  ACADIA Pharmaceuticals' (ACAD) CEO Uli Hacksell on Q1 2014 Results - Earnings Call Transcript at Seeking Alpha -5.20%
05:00PM  ACADIA Pharmaceuticals Earnings Call scheduled for 5:00 pm ET today CCBN
04:03PM  ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an EDGAR Online
04:01PM  ACADIA Pharmaceuticals Reports First Quarter 2014 Financial Results Business Wire
07:07AM  Q1 2014 ACADIA Pharmaceuticals Earnings Release - After Market Close CCBN
01-May-14 09:00AM  ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences Business Wire
29-Apr-14 09:00AM  ACADIA Pharmaceuticals to Announce First Quarter 2014 Financial Results on May 6, 2014 Business Wire
28-Apr-14 01:07PM  Oncology Treatments Retain Pricing Power: A Wall Street Transcript Interview with Boris Peaker, Ph.D., Executive Director and Senior Analyst with Oppenheimer & Co. Covering the Biotechnology Sector Wall Street Transcript
25-Apr-14 11:53AM  Wall Street Transcript Interview with Bernd Liesenfeld, the President of Quick-Med Technologies, Inc. (QMDT) Wall Street Transcript -5.99%
20-Apr-14 07:00AM  Acadia Pharmaceuticals: 4 Different Insiders Have Sold Shares This Month at Seeking Alpha
16-Apr-14 03:00PM  Is this March 2000? at MarketWatch +5.01%
15-Apr-14 12:23PM  The Recent Performance of 'Baker Brother Biotech Stocks' is Awful at TheStreet
11-Apr-14 05:08PM  ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
01-Apr-14 09:00AM  ACADIA Pharmaceuticals to Present at the 13th Annual Needham Healthcare Conference on April 8, 2014 Business Wire
28-Mar-14 04:58PM  3 Biotech Stocks Trading The Wrong Direction In March at Seeking Alpha
18-Mar-14 12:13PM  Puritan Fund's Flexible Approach to Investing Leads to Emphasis on U.S. Equities: A Wall Street Transcript Interview with Ramin Arani, a Portfolio Manager at Fidelity Management & Research Company Wall Street Transcript
11-Mar-14 05:06PM  ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Ex EDGAR Online
10-Mar-14 12:16PM  Insider Trading Alert - ACAD, FOSL And GPRE Traded By Insiders at TheStreet
07-Mar-14 09:06AM  ACADIA price target raised to $42 from $28 at Piper Jaffray theflyonthewall.com
05-Mar-14 04:23PM  ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
06:00AM  ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences Business Wire
04-Mar-14 07:28PM  ACADIA Pharmaceuticals Prices Public Offering of Common Stock Business Wire +6.56%
03-Mar-14 04:02PM  ACADIA files to sell $150M in common stock at theflyonthewall.com
04:01PM  ACADIA Pharmaceuticals Announces Proposed Public Offering of Common Stock Business Wire
01-Mar-14 09:34AM  An Update On Acadia Pharmaceuticals at Seeking Alpha
28-Feb-14 02:04PM  Cynapsus Represents A Compelling Acquisition Target For Acadia Pharmaceuticals at Seeking Alpha -5.98%
11:55AM  ACADIA Pharmaceuticals (ACAD) Is Water-Logged And Getting Wetter Today at TheStreet
27-Feb-14 08:50PM  ACADIA Pharmaceuticals Management Discusses Q4 2013 Results - Earnings Call Transcript at Seeking Alpha
05:00PM  ACADIA Pharmaceuticals Earnings Call scheduled for 5:00 pm ET today CCBN
04:04PM  ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an EDGAR Online
04:01PM  ACADIA Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2013 Business Wire
07:07AM  Q4 2013 ACADIA Pharmaceuticals Earnings Release - After Market Close CCBN
26-Feb-14 02:31PM  Acadia Pharmaceuticals: Here's What You Should Know About Its Surging Shares at Motley Fool
24-Feb-14 01:43AM  ACADIA Pharmaceuticals (ACAD) Jumps: Stock Rises 17.3% Zacks
21-Feb-14 11:19AM  Watch Out: Barbarians At The Gate For ACADIA Pharmaceuticals (ACAD) at TheStreet +17.33%
20-Feb-14 09:00AM  ACADIA Pharmaceuticals to Announce Fourth Quarter and Full Year 2013 Financial Results on February 27, 2014 Business Wire
11-Feb-14 08:31AM  Baker Brothers' Holding Cerus Flying Under The Radar With Catalyst Upcoming at Seeking Alpha
05-Feb-14 12:00PM  Commit To Purchase Acadia Pharmaceuticals At $15, Earn 17.9% Annualized Using Options at TheStreet
30-Jan-14 06:36PM  Lightning Round: Altria, Gogo & More at CNBC
23-Jan-14 09:05AM  Notes From One-On-One Meetings During San Fran Biotech Week - Day 1 at Seeking Alpha
21-Jan-14 08:31AM  Upside in biotech, cloud, materials? optionMONSTER
20-Jan-14 08:31AM  Upside in biotech, cloud, materials? optionMONSTER
13-Jan-14 04:08PM  ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
07-Jan-14 10:08AM  Healthcare Stocks To Avoid This Year at Seeking Alpha
07:33AM  This tiny mutual fund is no. 1 for 2013 at MarketWatch
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in neurological and related central nervous system disorders. The company has a pipeline of product candidates led by Pimavanserin that is in the Phase III development as a first-in-class treatment for Parkinson's disease psychosis, and in Phase II development for Alzheimer's disease psychosis; and has completed Phase II trial as a co-therapy for schizophrenia. It also has clinical-stage programs for chronic pain and glaucoma in collaboration with Allergan, Inc. and two advanced preclinical programs directed at Parkinson's disease and other neurological disorders. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hacksell UliCEOOct 08Option Exercise2.0030,00060,00030,000Oct 10 05:30 PM
Hacksell UliCEOOct 08Sale24.1530,000724,530115,549Oct 10 05:30 PM
Brege LauraDirectorSep 15Option Exercise1.7510,00017,50010,000Sep 16 06:05 PM
Brege LauraDirectorSep 15Sale28.0710,000280,6690Sep 16 06:05 PM
Wells William McDowallDirectorSep 12Option Exercise1.369,19012,4989,190Sep 16 06:04 PM
Wells William McDowallDirectorSep 12Sale29.159,190267,8730Sep 16 06:04 PM
Hacksell UliCEOSep 10Option Exercise2.0030,00060,00030,000Sep 12 05:56 PM
Hacksell UliCEOSep 10Sale27.3630,000820,821115,549Sep 12 05:56 PM
Wells William McDowallDirectorSep 02Option Exercise1.3630,00040,80030,000Sep 04 06:06 PM
KAPLAN LESTER J PH DDirectorSep 02Option Exercise1.3057,69275,00066,192Sep 04 06:11 PM
Wells William McDowallDirectorSep 02Sale26.8830,000806,4000Sep 04 06:06 PM
KAPLAN LESTER J PH DDirectorSep 02Sale26.7657,6921,543,8388,500Sep 04 06:11 PM
Hacksell UliCEOAug 15Option Exercise6.8615,000102,90015,000Aug 15 05:44 PM
Hacksell UliCEOAug 15Sale22.8915,000343,371115,549Aug 15 05:44 PM
Hacksell UliCEOJul 14Option Exercise6.8620,000137,20020,000Jul 16 06:00 PM
Hacksell UliCEOJul 14Sale22.2220,000444,374115,549Jul 16 06:00 PM
Hacksell UliCEOJun 16Option Exercise6.8620,000137,20020,000Jun 18 05:59 PM
Hacksell UliCEOJun 16Sale23.1020,000462,004115,549Jun 18 05:59 PM
Wells William McDowallDirectorJun 09Option Exercise1.6015,00024,00015,000Jun 10 06:08 PM
Wells William McDowallDirectorJun 09Sale23.0315,000345,4560Jun 10 06:08 PM
Rasmussen TorstenDirectorMay 01Option Exercise10.4632,857343,75341,357May 02 06:01 PM
Rasmussen TorstenDirectorMay 01Sale20.0332,857658,2348,500May 02 06:01 PM
Hacksell UliCEOApr 15Option Exercise6.9525,000173,75025,000Apr 17 06:00 PM
Hacksell UliCEOApr 15Sale17.7525,000443,835115,549Apr 17 06:00 PM
Aasen Thomas HEXEC VP, CFO AND CBOApr 04Option Exercise1.557,50011,62538,848Apr 04 07:51 PM
Rasmussen TorstenDirectorApr 04Option Exercise2.4030,00072,07538,500Apr 04 07:52 PM
Brege LauraDirectorApr 04Option Exercise1.7514,28524,99914,285Apr 04 07:52 PM
Rasmussen TorstenDirectorApr 04Sale21.9830,000659,3858,500Apr 04 07:52 PM
Aasen Thomas HEXEC VP, CFO AND CBOApr 04Sale22.4815,000337,2600Apr 04 07:51 PM
Brege LauraDirectorApr 04Sale22.5414,285321,9250Apr 04 07:52 PM
BAKER BROS. ADVISORS LPDirectorMar 05Buy28.50526,31615,000,00618,476,847Mar 07 05:27 PM
Baity GlennVP AND GCFeb 26Option Exercise6.1742,000259,14089,788Feb 28 05:48 PM
Baity GlennVP AND GCFeb 26Sale30.2842,0001,271,71847,788Feb 28 05:48 PM
Hacksell UliCEOFeb 18Option Exercise6.9525,000173,75025,000Feb 20 06:29 PM
Hacksell UliCEOFeb 18Sale24.1425,000603,528115,549Feb 20 06:29 PM
Hacksell UliCEOJan 15Option Exercise6.9525,000173,75025,000Jan 17 05:43 PM
Brege LauraDirectorJan 15Option Exercise1.3610,00013,60010,000Jan 17 05:43 PM
Hacksell UliCEOJan 15Sale24.0125,000600,288115,549Jan 17 05:43 PM
Brege LauraDirectorJan 15Sale24.1810,000241,7640Jan 17 05:43 PM
Aasen Thomas HEXEC VP, CFO AND CBOJan 02Option Exercise1.5522,00034,10061,348Jan 03 07:03 PM
Iversen Leslie LDirectorJan 02Option Exercise1.7460,000104,23073,500Jan 03 07:04 PM
Iversen Leslie LDirectorJan 02Sale25.0360,0001,501,75213,500Jan 03 07:04 PM
Aasen Thomas HEXEC VP, CFO AND CBOJan 02Sale24.8830,000746,3340Jan 03 07:03 PM
Hacksell UliCEODec 17Option Exercise1.556,50010,0756,500Dec 18 07:03 PM
Aasen Thomas HEXEC VP, CFO AND CBODec 12Option Exercise2.0012,00024,00039,348Dec 16 05:43 PM
Brege LauraDirectorDec 10Option Exercise1.3644,11759,99944,117Dec 12 06:15 PM
Brege LauraDirectorDec 10Sale23.4144,1171,032,9110Dec 12 06:15 PM
Hacksell UliCEODec 02Option Exercise2.0015,00030,00015,000Dec 04 06:11 PM
Hacksell UliCEODec 02Sale23.4515,000351,807109,049Dec 04 06:11 PM
Hacksell UliCEONov 01Option Exercise2.0015,00030,00015,000Nov 01 07:59 PM
Rasmussen TorstenDirectorNov 01Option Exercise1.3037,69249,00046,192Nov 01 07:59 PM
Rasmussen TorstenDirectorNov 01Sale23.0037,692867,0338,500Nov 01 07:59 PM
Hacksell UliCEONov 01Sale23.2415,000348,638109,049Nov 01 07:59 PM